Black cohosh has been studied more than any other plant product sold for menopause. The results are still inconsistent.
Some trials of specific standardized extracts report reductions in hot flashes greater than placebo. Others find no difference at all. Reviews that pull the studies together have concluded the evidence isn’t enough to establish a benefit.
Current professional guidance reflects that. The Menopause Society’s 2023 statement on non-hormone treatments doesn’t recommend supplements or herbal remedies, including this one, for hot flashes and night sweats.
That’s not the same as saying it’s been proven useless. It’s worth understanding the difference, because the two get confused constantly.
What is Black Cohosh?
Black cohosh is a flowering plant native to eastern North America. Its botanical name is Actaea racemosa, previously Cimicifuga racemosa.
It has a long history of traditional use, including by Native American peoples, and entered European herbal medicine in the nineteenth century.
Products sold today differ in the part of the plant used, the extraction method, the concentration, and the daily dose. Trials have most often used standardized extracts at doses between twenty and eighty milligrams a day. That variation matters more than it sounds, and it comes up again below.
How it is thought to work
It was originally assumed to act as a phytoestrogen, meaning a plant compound with estrogen-like activity.
That explanation is no longer well supported. Black cohosh doesn’t bind estrogen receptors in the way that assumption requires.
Current proposals focus on effects on serotonin pathways and other brain mechanisms involved in temperature control.
The mechanism remains unresolved. That’s relevant to safety as well as to whether it works, because you can’t predict the risks of something when you don’t know how it acts.
Why the trial results differ
Product variability is the most likely explanation. Different extracts aren’t interchangeable. A trial of one specific extract doesn’t tell you about a different product with the same plant name on the label. Trials also vary in length, in how severe symptoms were at the start, and in how results were measured.
Then there’s placebo. The placebo response in hot flash trials is large. In the trials supporting a recent prescription drug approval, women taking a dummy pill recorded a 47 percent reduction in moderate to severe hot flashes over twelve weeks. That figure is worth holding onto. It means any trial without a placebo group tells you almost nothing in this field, and it means your own experience of improvement can’t settle the question either.
Liver safety
Cases of liver injury, some serious, have been reported in people taking black cohosh. A number required hospitalization, and a small number involved liver failure.
The cause hasn’t been established. The reports are rare relative to how widely it’s used. Contamination or misidentification of plant material may explain some cases, and other causes were found in others.
Regulators in several countries have nonetheless required liver injury warnings on these products. It hasn’t been treated as a settled question in either direction.
If you take black cohosh and develop yellowing of the skin or eyes, dark urine, persistent nausea, or pain in the upper right of your abdomen, stop and seek medical advice.
Other safety considerations
Black cohosh is generally well tolerated. Trials report only mild and occasional side effects such as headache, rash, and stomach upset. Studies lasting up to twelve months found no evidence that it stimulates the uterine lining. Long-term safety beyond that period hasn’t been established. Its safety for women with a history of breast cancer or other hormone-sensitive conditions remains unresolved.
One more thing, and it matters. Don’t confuse black cohosh with blue cohosh. They’re entirely unrelated plants, and blue cohosh has a different and more concerning safety profile.
What this means in practice
The position isn’t that black cohosh has been proven ineffective. It’s that the evidence hasn’t established that it works, and that a rare but serious safety signal exists alongside that uncertainty.
Guidance doesn’t recommend it for hot flashes, and options with clearer evidence are available in both hormonal and non-hormonal categories.
Because supplements in the United States aren’t checked before sale, what’s actually in the bottle isn’t verified unless the manufacturer pays for independent testing. A USP or NSF seal confirms contents and purity. It says nothing about whether the product works.
If you decide to try it anyway, tell your provider. That’s not a formality. It matters for anyone with liver concerns, anyone taking other medicines, and anyone with a hormone-sensitive condition.
The evidence is inconsistent. Some trials of specific extracts show benefit against placebo, others show none, and reviews conclude the evidence isn’t enough to establish it.
No. The Menopause Society’s 2023 statement doesn’t recommend supplements or herbal remedies for hot flashes and night sweats.
Mostly because products differ. Extracts aren’t interchangeable, so a trial of one doesn’t test another. Trial length, symptom severity, and outcome measures vary too.
That was the original assumption, but it isn’t well supported. Black cohosh doesn’t bind estrogen receptors the way that explanation requires.
Rare cases of serious liver injury have been reported, without a cause being established. Several countries require liver warnings on these products.
Yellowing of the skin or eyes, dark urine, persistent nausea, or pain in the upper right abdomen. Seek medical advice.
The evidence is unresolved for women with breast cancer or other hormone-sensitive conditions. Discuss it with your oncology team rather than deciding alone.
No. It’s an entirely unrelated plant with a different and more concerning safety profile. Don’t substitute one for the other.
The Bottom Line
Black cohosh is the most studied herbal option for menopause, and after all that study the evidence still doesn’t establish that it works. Products differ enough that trial results may not apply to what you’d actually buy.
Set against that is a rare but real signal of serious liver injury with no established cause. That combination is why guidance doesn’t recommend it.
If you want to try it regardless, that’s your decision to make. Tell your provider, choose a product with a USP or NSF seal so you at least know what’s in it, and stop if you develop any sign of liver trouble.
